Molina Healthcare (MOH) has been recently surrounded by
legal challenges and
class action lawsuits, drawing attention from several law firms that are alerting shareholders and investors for potential large losses. Despite that, MOH is the driving force of
S&P 500 Index Growth. Various financial firms have given their perspectives on MOH's valuation following the class-action lawsuits and revised earnings guidance, with
Sell (D+) Rating from Weiss Ratings and a targeted price raised by
Wells Fargo. The company recently announced preliminary second quarter financial results and updated Fiscal Year 2025 earnings per share guidance. Additionally, MOH has seen
resilient growth despite Medicaid headwinds, signed CEO Joe Zubretsky to a new employment agreement, planning to expand the role of Senior Executive Vice President and CFO Mark Keim, and takes steps towards acquisitions, including ConnectiCare and Cignaβs Texas Medicaid Contracts.
Molina Healthcare MOH News Analytics from Tue, 23 Mar 2010 07:00:00 GMT to Sat, 11 Oct 2025 10:18:00 GMT -
Rating -2
- Innovation 1
- Information 4
- Rumor -2
